CO2017009515A2 - Análogos de ferruginol como agentes antivirales - Google Patents

Análogos de ferruginol como agentes antivirales

Info

Publication number
CO2017009515A2
CO2017009515A2 CONC2017/0009515A CO2017009515A CO2017009515A2 CO 2017009515 A2 CO2017009515 A2 CO 2017009515A2 CO 2017009515 A CO2017009515 A CO 2017009515A CO 2017009515 A2 CO2017009515 A2 CO 2017009515A2
Authority
CO
Colombia
Prior art keywords
ferruginol
analogs
antiviral agents
alkylamide
stereochemistry
Prior art date
Application number
CONC2017/0009515A
Other languages
English (en)
Inventor
Galvis Liliana Amparo Betancur
Cardenete Miguel Ángel González
Original Assignee
Univ Antioquia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Antioquia filed Critical Univ Antioquia
Publication of CO2017009515A2 publication Critical patent/CO2017009515A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/17Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings containing other rings in addition to the six-membered aromatic rings, e.g. cyclohexylphenol
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Análogos de Ferruginol como agentes antivirales La presente invención se refiere a un análogo de ferruginol de fórmula (I) en la que R1, R2 R3 y X tienen independientemente el significado siguiente: - R1 es CH2-ftalimido, CH2-succinimido, CH2-maleimido, CH2-NHCOCH3, CH2-NHCOCF3, CHO, CH2OH, (C1-C6)carboxiester, o CH3 y donde R1 tiene cualquier estereoquímica, - R2 es H, OH, F, Cl, Br, NO2, NH2, (C1-C6)alquilamino, di(C1-C6)alquilamino, (C1-C6)alquilamida o di(C1-C6)alquilamida, - R3 es H o OH, - X es H2, O, OH o NOH, donde X puede tener cualquier esteroquímica en el caso apropiado, como cuando es OH, incluyendo cualquier estereoisómero, para su uso como antiviral, especialmente para su uso contra virus envueltos, y de forma especialmente preferida contra el virus del dengue y herpes.
CONC2017/0009515A 2015-03-12 2017-09-20 Análogos de ferruginol como agentes antivirales CO2017009515A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201530320A ES2586505B1 (es) 2015-03-12 2015-03-12 Análogos de ferruginol como agentes antivirales
PCT/ES2016/070164 WO2016142568A1 (es) 2015-03-12 2016-03-14 Análogos de ferruginol como agentes antivirales

Publications (1)

Publication Number Publication Date
CO2017009515A2 true CO2017009515A2 (es) 2018-01-16

Family

ID=56879247

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2017/0009515A CO2017009515A2 (es) 2015-03-12 2017-09-20 Análogos de ferruginol como agentes antivirales

Country Status (3)

Country Link
CO (1) CO2017009515A2 (es)
ES (1) ES2586505B1 (es)
WO (1) WO2016142568A1 (es)

Also Published As

Publication number Publication date
ES2586505B1 (es) 2017-07-13
WO2016142568A1 (es) 2016-09-15
ES2586505A1 (es) 2016-10-14

Similar Documents

Publication Publication Date Title
CR20150337A (es) Derivados de pirimidinona y su uso en el tratamiento, mejora o prevencion de una enfermedad viral
CL2018000952A1 (es) Compuestos útiles como inmunomoduladores
CO2018010748A2 (es) Agentes antivirales contra la hepatitis b
GT201600086A (es) Pirrolo[12-f][1,2,4]triazinas útiles para tratar infecciones por el virus sincitial respiratorio
CR20160337A (es) Nuevas heteroarildihidropirimidinas 6-fusionadas para el tratamiento y la profilaxis de la infección por virus de la hepatitis b
CR20160241A (es) Nuevas dihidroquinolizinonas para el tratamiento y profilaxis de la infección por virus de la hepatitis b
GT201500005A (es) Composiciones de vacuna para la prevencion contra la infeccion por el virus del dengue
CR20180232A (es) Macrociclos peptídicos contra acinetobacter baumannii
BR112016028773A2 (pt) processos para preparação de compostos antivirais
CR20210079A (es) Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b
CL2018001192A1 (es) Análogos de saponina triterpeno
UY35237A (es) Composiciones que comprenden un compuesto de triazol
BR112017022209A2 (pt) composição aquosa que compreende éster de ácido omega- aminocarboxílico e álcool graxo e seu uso
UY35238A (es) Composiciones que comprenden un compuesto de triazol
ECSP17057131A (es) Desacetoxitubulisina h y análogos de esta
CR20150231A (es) Composiciones herbicidas de baja volatilidad
DOP2011000268A (es) Vacuna inactivada del virus del dengue con un adjuvante libre de aluminio
BR112015027432A2 (pt) 3-(4-isobutil-2-metilfenil)propanal como ingrediente de perfume
MX2012013564A (es) Composicion de pantalla solar.
BR112017002478A2 (pt) aminas com baixo teor de voc como um componente surfactante em dispersões
UY35446A (es) 2?((4?AMINO?3?(3?FLUOR?5?HIDROXIFENIL)?1H?PIRAZOLO[3,4?D]PIRIMIDIN?1?IL)METIL)?5?(3?(2?(2?METOXIETOXI)ETOXI)PROP?1?IN?1?IL)?3?(2?(TRIFLUORMETIL)BENCIL)QUINAZOLIN?4(3H)?ONA COMO INHIBIDOR DUAL DE PI3K d/g
BR112013020719A2 (pt) composições de derivados de bimatoprost tipo éster e métodos
GT201500247A (es) Imidazopiridazinas sustituidas
ECSP14004595A (es) 2-tiopirimidinonas
BR112017004197A2 (pt) composições de vacina contra doenças do vírus da dengue